Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44399 clinical trials with a EudraCT protocol, of which 7411 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,399)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,399 result(s) found. Displaying page 1,456 of 2,220.

EudraCT Number: 2017-002811-33

Sponsor Protocol Number: LAINCO1107

Start Date*: 2017-12-11

Sponsor Name:LAINCO S.A

Full Title: Unilateral, open and randomized phase IV study of 2 groups to assess the degree of comfort with simple Emuliquen® in patients undergoing proctological surgery

Medical condition: Surgery proctological

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000016398	10042759	Symptoms involving digestive system	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2015-005761-23

Sponsor Protocol Number: CTD-TCNPC-201

Start Date*: 2016-09-26

Sponsor Name:Cyclo Therapeutics, Inc.

Full Title: A Phase I/II study to evaluate the safety and pharmacokinetics of intravenous Trappsol Cyclo (HP-β-CD) in patients with Niemann-Pick disease type C (NPC-1) and the pharmacodynamic effects of treatm...

Medical condition: Niemann-Pick disease type C

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10010331 - Congenital, familial and genetic disorders	10029403	Niemann-Pick disease	PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) SE (Completed) IT (Ongoing)

Trial results: View results

EudraCT Number: 2006-003133-33	Sponsor Protocol Number: EMG-2006	Start Date*: 2006-07-14
Sponsor Name:Hôpital Erasme
Full Title: Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe.
Medical condition: healthy subjects obstructive sleep apnea (Bosentan is used in clinic in pulmonary hypertension)
Disease:
Population Age: Adults		Gender: Male
Trial protocol: BE (Completed)
Trial results: View results

EudraCT Number: 2013-004328-12

Sponsor Protocol Number: Europe

Start Date*: 2015-01-23

Sponsor Name:GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH

Full Title: Prospective validation of a predictive model of response to romiplostim in patients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia - the EUROPE-trial

Medical condition: Patients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004864	10068361	MDS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) FR (Ongoing) CZ (Completed)

Trial results: View results

EudraCT Number: 2007-004620-20

Sponsor Protocol Number: P3

Start Date*: 2008-05-21

Sponsor Name:department of Pharmacology-Toxicology RUNMC

Full Title: Persantin Preceding PCI

Medical condition: myocardial damage due to PCI

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10065554	Myocardial infarction prophylaxis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2006-004878-28

Sponsor Protocol Number: dipy001

Start Date*: 2006-12-27

Sponsor Name:UMCN farm-tox

Full Title: Does caffeine reduce dipyridamole-induced protection against ischemia-reperfusion injury?

Medical condition: Reperfusion after an ischemic accident will limit tissue damage (infacrt size), though on the other hand reperfusion injury will also cause tissue damage by the release of ROS and facilitating cell...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10062828	Ischemic heart disease prophylaxis	LLT

Population Age: Adults

Gender: Male

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2007-005789-11

Sponsor Protocol Number: atorv02

Start Date*: 2008-03-11

Sponsor Name:RUNMC

Full Title: Does atorvastatin have an acute and prolonged inhibitory effect on ischemia-reperfusion injury in humans in-vivo?

Medical condition: ischemia-reperfusion injury

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10023033	Ischemia myocardial	LLT

Population Age: Adults

Gender: Male

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2019-003644-68

Sponsor Protocol Number: V114-033

Start Date*: 2021-12-07

Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparatorcontrolled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants

Medical condition: Prevention of pneumococcal disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10021881 - Infections and infestations	10061353	Pneumococcal infection	PT

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: Outside EU/EEA

Trial results: View results

EudraCT Number: 2006-000815-24	Sponsor Protocol Number: 01-2006	Start Date*: 2006-07-28
Sponsor Name:Charité
Full Title: A randomized study of topical 3% Diclofenac in a 2.5% Hyaluronate base (Solaraze® 3% Gel) versus topical 5% 5-Fluorouracil (Efudix® Cream) versus liquid nitrogen spray cryotherapy in immunosufficie...
Medical condition: Actinic keratosis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2007-000151-33

Sponsor Protocol Number: rosu01

Start Date*: 2007-04-02

Sponsor Name:UMCN

Full Title: Does caffeine reduce rosuvastatin-induced protection against ischemia-reperfusion injury?

Medical condition: Rosuvastatin is a proven cholesterol lowering medicine. Apart from it’s cholesterol lowering action, rosuvastatin may also increase tolerance against ischemia-reperfusion injury. We hypothesize tha...

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10000891	Acute myocardial infarction	LLT
	9.1		10023033	Ischemia myocardial	LLT

Population Age: Adults

Gender: Male

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2007-005893-29

Sponsor Protocol Number: atp01

Start Date*: 2008-08-14

Sponsor Name:RUNMC

Full Title: Does ATP cause Annexin A5 targeting in the human forearm?

Medical condition: atherosclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10003601	Atherosclerosis	LLT

Population Age: Adults

Gender: Male

Trial protocol: NL (Completed)

Trial results: View results

EudraCT Number: 2011-004977-10

Sponsor Protocol Number: 08meInnereA_GALACTIC

Start Date*: 2013-07-25

Sponsor Name:University Hospital Basel, Cardiology

Full Title: Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study

Medical condition: - acute decompensated heart failure

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.0	10042613 - Surgical and medical procedures	10054112	Hospitalisation	PT
	19.0	10018065 - General disorders and administration site conditions	10011906	Death	PT
	19.0	10042613 - Surgical and medical procedures	10022519	Intensive care	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prohibited by CA) BG (Completed)

Trial results: View results

EudraCT Number: 2015-001832-39

Sponsor Protocol Number: LPS14060

Start Date*: 2015-11-03

Sponsor Name:sanofi-aventis Groupe

Full Title: A twenty-six week, randomized, open-label, 2-arm parallel group real world pragmatic trial to assess the clinical and health outcomes benefit of transition to Toujeo compared to standard of care in...

Medical condition: Type 2 diabetes mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.1	10027433 - Metabolism and nutrition disorders	10067585	Type 2 diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) IE (Completed) FI (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2015-005431-41

Sponsor Protocol Number: BN40900(SA-309JG)

Start Date*: 2017-10-16

Sponsor Name:F. Hoffmann-La Roche Ltd.

Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Satralizumab (SA237) as Monotherapy in Patients With Neuromyelitis Optica (NMO) and...

Medical condition: Neuromyelitis optica (NMO) and NMO spectrum disorder (MNOSD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004852	10029322	Neuromyelitis optica	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Completed) RO (Completed) HR (Completed)

Trial results: View results

EudraCT Number: 2018-004563-31	Sponsor Protocol Number: Au18-12	Start Date*: 2022-07-25
Sponsor Name:Centre Hospitalier Universitaire de Reims
Full Title: Cell therapy in Critical Limb Ischemia by implantation of allogeneic umbilical cord-derived mesenchymal stem cells
Medical condition: Evaluation of the feasibility and systemic and local tolerance of an implantation, via intramuscular route, of allogenic HB-MSC1, associated with a revascularization procedure, in patients sufferin...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2015-005307-83

Sponsor Protocol Number: CL04041023

Start Date*: 2017-03-03

Sponsor Name:R-Pharm

Full Title: A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with Moderately to Severely Active Rheum...

Medical condition: Moderately to Severely Active Rheumatoid Arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10028395 - Musculoskeletal and connective tissue disorders	10039073	Rheumatoid arthritis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LV (Completed) CZ (Completed) DE (Completed) LT (Completed) HU (Completed) PL (Completed) BG (Completed) RO (Completed)

Trial results: View results

EudraCT Number: 2015-005555-27	Sponsor Protocol Number: ESR-14-10473	Start Date*: 2017-09-12
Sponsor Name:University Hospital Basel
Full Title: Prevention of Cerebral Ischaemia in Stent Treatment for Carotid Artery Stenosis - A randomised multi-centre phase II trial comparing Ticagrelor versus Clopidogrel with outcome assessment on MRI (PR...
Medical condition: Carotid artery stenting (CAS) is treatment for atherosclerotic carotid stenosis. The main adverse events are thromboembolic brain infarcts during the procedure. Ticagrelor, a novel reversible inhib...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed) NL (Completed) GB (GB - no longer in EU/EEA) BE (Completed)
Trial results: (No results available)

EudraCT Number: 2007-000842-11	Sponsor Protocol Number: 18-122	Start Date*: 2007-10-15
Sponsor Name:Medical University of Graz
Full Title: 99Tc labled Inliximab for evaluation of inflammatory activity in patients with inflammtory bowel disease (IBD)
Medical condition: Inflammatory bowel disease Crohn´s disease Ulcerative colitis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2007-007200-16

Sponsor Protocol Number: ISS T-002

Start Date*: 2008-06-13

Sponsor Name:ISTITUTO SUPERIORE DI SANITA'

Full Title: A Phase II randomized, open label, immunogenicity and safety trial of the vaccine based on the recombinant biologically active HIV-1 Tat protein in anti-Tat negative HIV-1 infected HAART-treated ad...

Medical condition: HIV-1 infected subjects

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10020161	HIV infection	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2020-005839-76

Sponsor Protocol Number: PDE5I-UPR-AAR-01

Start Date*: 2021-02-15

Sponsor Name:University hospital Bispebjerg and Frederiksberg, Department of Clinical Pharmacology

Full Title: Effects of single dose tadalafil on urethral and anal closure function and on urinary flow in healthy females: A randomised, controlled, double-blinded, two-period cross-over study

Medical condition: Urinary stress incontinence and fecal incontinence

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	22.0	10022891 - Investigations	10022891	Investigations	SOC

Population Age: Adults

Gender: Female

Trial protocol: DK (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Jun 16 03:46:27 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA